Pharma and IT stocks faced heavy pressure after Trump’s 100% tariff and H-1B visa fee hike, dragging Nifty lower. Laurus Labs showed a topping pattern while Wockhardt stayed in consolidation. Nifty IT ...

Airtel, Oberoi Realty, BEL, MCX, TCS, Hindustan Zinc, Lodha Developers and more are on the radar of market experts for intraday trading today. Let's take a look at shares target price and stop loss be ...

Should you add shares of Dixon Technologies (India) Ltd.? Should you hold shares of NCC Ltd. at the current market price? Have you lost the chance to buy shares of Dr Reddy's Laboratories Ltd. at an ...

BSE Midcap index rose 0.3 percent, while smallcap index shed 0.3 percent. Axis Bank, Maruti Suzuki, L&T, Adani Enterprises, Dr Reddy's Labs were among top losers on the Nifty, while gainers were ...

Tata Motors, Trent, Shriram Finance, TCS, Power Grid were among major losers on the Nifty, while gainers were Bharat Electronics, Hindalco, Axis Bank, ONGC, Hero MotoCorp. On the sectoral front, ...

Strathfield proved to be a hot market last week with 13 properties selling for a total value of $32.9 million. See the latest auction and sales results. The property at 75 Cutler Rd sold for $20.5 ...

All products featured on Vogue are independently selected by our editors. However, we may receive compensation from retailers and/or from purchases of products through these links. “Lab-grown diamonds ...

The University of Nevada celebrated the opening of its new John Tulloch Business Building, showcasing updated resources for student collaboration, workforce preparation, and a state-of-the-art trading ...

This is not a drill—the 2025 MarketingProfs B2B Forum program is here! You won't want to miss the lineup of incredible speakers and insightful, inspirational sessions they're bringing to B2B Forum ...

BGauss RUV 350 Price in Saharsa starts from 1.10 lakh. Check 2024 BGauss RUV 350 on-road price (Ex-Showroom + RTO + Insurance) and explore the best offers in Saharsa, only on Autocar India.

The FDA has rejected a biologics license application for apitegromab to treat spinal muscular atrophy, according to manufacturer Scholar Rock.